Context Therapeutics Inc. (CNTX) Misses Q3 EPS by 17c
Tweet
Share
E-mailGet Alerts CNTX Hot Sheet
Join SI Premium – FREE
Context Therapeutics Inc. (NASDAQ: CNTX) reported Q3 EPS of ($0.22), $0.17 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .
For earnings history and earnings-related data on Context Therapeutics Inc. (CNTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight
- Goldman Sachs Starts Luckin Coffee (LKNCY) at Buy
- Morgan Stanley Downgrades Melco Resorts (MLCO) to Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
